Healthy volunteers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Females aged 50-69 years who experienced natural menopause over a year ago 2) Subjects whose levels of bone mineral density measurement are more than Young Adult Mean (YAM) -2.5 SD and less than YAM -1.0 SD 3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects receiving medical treatments for osteoporosis 2) Subjects with serious cardio-vascular, hepatic, renal, respiratory, endocrine, metabolic disorders or a medical history of these disorders 3) Subjects who take regularly pharmaceuticals and quasi-drugs which have the efficacy for bone mineral density or bone metabolism 4) Subjects who take regularly Foods for Specified Health Uses, Foods with Function Claims and supplements which have the possibility of the effects on bone mineral density or bone metabolism 5) Subjects who have the possibility of developing allergic symptoms by the test food 6) Subjects having blood sample of 200 ml or more taken within one month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 7) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 8) Subjects deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density (lumber spine (L2-L4), proximal femur) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood analysis (BAP, TRACP-5b, NTX) | — |
Countries
Japan
Contacts
Soiken Inc. R&D Division